Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
- Status
- COMPLETED
- Phase
- N/A
Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
- Status
- WITHDRAWN
- Phase
- PHASE1
Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
- Status
- TERMINATED
- Phase
- NA
Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Non-interventional Study on Time to Response and Quality of Life in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide in Second Line
- Status
- COMPLETED
- Phase
- N/A
Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
- Status
- TERMINATED
- Phase
- NA